While oligosaccharides are abundantly present in nature, the richness (concentration and diversity) in human milk is truly remarkable.
HMOs are the 3rd most important component in human milk, next to lactose and lipids. The diversity encompasses more than 200 different glycan structures. The exact composition is unique for every woman whereby HMO concentration is determined, amongst others, by genetic factors and stage of lactation.
The first HMO that became commercially available is 2’-Fucosyllactose, abbreviated 2’FL.
Inbiose has the technology ready for mass production of 2’FL and several other HMO structures. Today, it is technically possible to enrich infant formula with HMOs so that, on average, more than 50% of the HMO concentration in mothers’ milk can be mimicked.
But it doesn’t stop here; Inbiose continues to invest and expand its proprietary Glycoactives® technology, aiming to offer other, more complex HMO structures at an affordable cost, so that every human being, baby, adult or elderly person can enjoy the health benefits of HMOs.